← Leaderboards
Katherine Paige Lemon
Boston Children'S Hospital
$8,881,587
Attributed
$11,057,486
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,484,229 · 7
By mechanism
U19$15,195,090 · 3
R01$5,882,159 · 2
R35$2,036,000 · 1
K08$370,980 · 1
Top collaborators
- Michael Andrew Fischbach9 shared
- Robert A Britton6 shared
- Anthony W Maresso6 shared
- Katy Patras5 shared
Others in their field
Top investigators on “Bacteria”
- James E. Gern · University Of Wisconsin-Madison$138,333,846
- Ian A Wilson · Scripps Research Institute, The$90,122,969
- Vance G Fowler · Duke University$85,101,521
- Henry F Chambers · Duke University$84,838,080
- Timothy Henkel · Venatorx Pharmaceuticals, Inc.$48,397,895
- David Alland · Rutgers Biomedical And Health Sciences$47,292,355
Research focus
BacteriaInfectionNosePreventStreptococcus PneumoniaeInnovationCommunitiesSurfaceStaphylococcus AureusCoculture TechniquesGrowthCorynebacteriumMolecularNasal MicrobiotaEnvironmentInfection PreventionGenesCessation Of LifeMicrobiotaGeneticIn VitroMicrobial CommunityPathobiontResistance
Grant awards (35)
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$2,479,201
U19 · FY2025 · AI
Nasal Microbial Consortia Combat Antibiotic-Resistant Bacteria$646,639
U19 · FY2025 · AI · contact PI
Mechanisms of Corynebacterium-Dolosigranulum Interactions that Shape Human Nasal Microbiota$400,000
R35 · FY2025 · GM · contact PI
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$2,497,111
U19 · FY2024 · AI
Nasal Microbial Consortia Combat Antibiotic-Resistant Bacteria$542,044
U19 · FY2024 · AI · contact PI
Mechanisms of Corynebacterium-Dolosigranulum Interactions that Shape Human Nasal Microbiota$400,000
R35 · FY2024 · GM · contact PI
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$119,807
U19 · FY2024 · AI
Nasal Microbial Consortia Combat Antibiotic-Resistant Bacteria$119,807
U19 · FY2024 · AI · contact PI
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$2,537,842
U19 · FY2023 · AI
Nasal Microbial Consortia Combat Antibiotic-Resistant Bacteria$544,312
U19 · FY2023 · AI · contact PI
Mechanisms of Corynebacterium-Dolosigranulum Interactions that Shape Human Nasal Microbiota$400,000
R35 · FY2023 · GM · contact PI
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$2,402,665
U19 · FY2022 · AI
Nasal Microbial Consortia Combat Antibiotic-Resistant Bacteria$400,444
U19 · FY2022 · AI · contact PI
Mechanisms of Corynebacterium-Dolosigranulum Interactions that Shape Human Nasal Microbiota$400,000
R35 · FY2022 · GM · contact PI
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces$2,390,117
U19 · FY2021 · AI
Nasal Microbial Consortia Combat Antibiotic-Resistant Bacteria$515,101
U19 · FY2021 · AI · contact PI
Antibiotics from nose and throat commensals that impact pathogen colonization$484,679
R01 · FY2021 · AI · contact PI
Mechanisms of Corynebacterium-Dolosigranulum Interactions that Shape Human Nasal Microbiota$436,000
R35 · FY2021 · GM · contact PI
Antibiotics from nose and throat commensals that impact pathogen colonization$497,393
R01 · FY2020 · AI · contact PI
Antibiotics from nose and throat commensals that impact pathogen colonization$532,744
R01 · FY2019 · AI · contact PI
Impact of Commensal Corynebacterium Species on Pathogen Colonization and Microbiota Composition$303,974
R01 · FY2019 · GM · contact PI
Impact of commensal Corynebacterium species on pathogen colonization and microbiota composition$20,558
R01 · FY2019 · GM · contact PI
Antibiotics from nose and throat commensals that impact pathogen colonization$531,603
R01 · FY2018 · AI · contact PI
Impact of commensal Corynebacterium species on pathogen colonization and microbiota composition$416,892
R01 · FY2018 · GM · contact PI
Antibiotics from nose and throat commensals that impact pathogen colonization$542,086
R01 · FY2017 · AI · contact PI
Impact of commensal Corynebacterium species on pathogen colonization and microbiota composition$398,517
R01 · FY2017 · GM · contact PI
Impact of commensal Corynebacterium species on pathogen colonization and microbiota composition$13,455
R01 · FY2017 · GM · contact PI
Impact of commensal Corynebacterium species on pathogen colonization and microbiota composition$376,965
R01 · FY2016 · GM · contact PI
Antibiotics from nose and throat commensals that impact pathogen colonization$442,757
R01 · FY2015 · AI · contact PI
Antibiotics from nose and throat commensals that impact pathogen colonization$442,247
R01 · FY2014 · AI · contact PI
Antibiotics from nose and throat commensals that impact pathogen colonization$414,710
R01 · FY2013 · AI · contact PI
Antibiotics from nose and throat commensals that impact pathogen colonization$463,579
R01 · FY2012 · AI · contact PI
Biofilm Formation by Listeria monocytogenes$123,660
K08 · FY2008 · AI · contact PI
Biofilm Formation by Listeria monocytogenes$123,660
K08 · FY2007 · AI · contact PI
Biofilm Formation by Listeria monocytogenes$123,660
K08 · FY2006 · AI · contact PI